Stay updated on Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.

Latest updates to the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision tag on the page was updated from v3.6.4 to v3.6.5, signaling an updated build/version rather than changes to visible content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s revision marker was updated from v3.6.3 to v3.6.4, indicating a new version of the page content.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now shows a new revision tag: Revision: v3.6.3, replacing Revision: v3.6.2. This indicates a version update for the page content/assets.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a system update. This change does not alter the trial details, eligibility criteria, or any content shown to users.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page now indicates that recruitment has ended for this study and adds user-focused sections such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention label is updated to Intervention/Treatment and a new revision note (Revision: v3.6.0) appears, replacing the prior v3.5.5 note.SummaryDifference0.4%

- Check80 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page.SummaryDifference0.0%

Stay in the know with updates to Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy with Nivolumab in HIV+ Patients Clinical Trial page.